Power to the Patientsポッドキャストを聴こう

Inside the ALS Breakthrough: 20-Year Journey to FDA Approval with Dr. Joseph Palumbo	Power to the Patients	39:56
Why Clinical Trial Speed Kills Success - And What Top Sponsors Do Instead ft. Steve Brannan	Power to the Patients	40:54
Dr. Anantha Shekhar on the Convergence of Psychiatry, Neurology, and the Next Era of Brain Medicine	Power to the Patients	50:05
Ram Mukunda, CEO of IGC Pharma, on Innovation and Hope in Alzheimer’s Care	Power to the Patients	39:42
Brandon Bentzley, CSO and Co-founder of Magnus Medical, on Precision Psychiatry and Rewiring Depression	Power to the Patients	68:18
Sarah MacCallum & Melissa Gaines- Clinical Operations Leaders at Annovis Bio	Power to the Patients	50:28
Daniel O'Connell, CEO of Acumen Pharmaceuticals, on Oligomers, Innovation, and Hope in Alzheimer’s	Power to the Patients	45:45
Michael Gold, Chief R&D Officer at Compass Pathways	Power to the Patients	55:40
Matthew Leoni, CMO of Merida Biosciences, on Navigating the Challenges and Opportunities in Neuroscience Drug Development	Power to the Patients	56:17
Gerard Sanacora, Professor at Yale, on glutamate, GABA, and the next era of depression treatment	Power to the Patients	53:47
Backing Breakthroughs in Psychedelics	Power to the Patients	39:35
Joel Raskin, CMO of Arrivo Bio talks about unlocking the future of psychiatry	Power to the Patients	47:26
Dr. Jerry Rosenbaum & Dr. Sharmin Ghaznavi: Mass General Center on the Neuroscience of Psychedelics	Power to the Patients	42:33
Spyros Papapetropoulos, CEO of Neuphoria	Power to the Patients	42:17
Steve Gourlay, CEO of Actinogen	Power to the Patients	41:13
Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry	Power to the Patients	40:32
John Krystal: Advancing Ketamine Research & Psychiatry at Yale	Power to the Patients	61:02
Next-Gen Treatments for Anxiety and Depression Disorders	Power to the Patients	45:01
Precision Psychiatry and Emerging Technologies	Power to the Patients	63:28
From Culture to Care: The Framework of Patient Centricity	Power to the Patients	33:20
Unraveling Mysteries of the Brain Through Neuroscience Research	Power to the Patients	48:39
Harnessing Precision Medicine to Redefine Psychiatric Treatment	Power to the Patients	46:27
Breaking New Ground with Psilocybin	Power to the Patients	48:48
Bringing the Consumer Experience to Clinical Research	Power to the Patients	24:20
A New Frontier of Psychedelic Therapies	Power to the Patients	35:34
A Pragmatic Approach to Psychedelic Drug Development	Power to the Patients	49:46
Building a High Recruiting Site in Alzheimer's	Power to the Patients	45:40
Why Beckley Psytech is Developing the Next Generation of Psychedelics	Power to the Patients	38:56
The Mental Health Epidemic in Rural America	Power to the Patients	41:13
Going All In on Psilocybin for Depression	Power to the Patients	43:44
Psychedelics and the Future of Anxiety Relief	Power to the Patients	38:43
AliveAndKickn: Raising Awareness about Lynch Syndrome	Power to the Patients	35:15
Empowering Patients through Digital Platforms in Clinical Trials with Sasha Sinclair	Power to the Patients	28:30
Integrating Patient Experience in Clinical Trials with Farah Meghji	Power to the Patients	36:50
Patient-first Approaches in Clinical Trials with Megan Liles	Power to the Patients	43:13
Patient-informed clinical trial development with Victoria DiBiaso, VP & Global Head Patient Informed Development & Health Value Translation at Sanofi	Power to the Patients	30:24
Integrating patient centricity culturally and operationally, with Dr. Anthony Yanni, Sr. VP and Head of Patient Centricity at Astellas	Power to the Patients	27:40
Exploring Technology and Patient Engagement in Clinical Trials with Bryan Wylie	Power to the Patients	31:00
Patient advocacy with Stephanie E. Saville, Foundation Manager for the Pediatric Retinal Research Foundation	Power to the Patients	26:22
Oncology trial strategy with Deb Kientop, VP Clinical Operations at Deka Biosciences	Power to the Patients	44:42

Inside the ALS Breakthrough: 20-Year Journey to FDA Approval with Dr. Joseph Palumbo

Power to the Patients

39:56

Why Clinical Trial Speed Kills Success - And What Top Sponsors Do Instead ft. Steve Brannan

Power to the Patients

40:54

Dr. Anantha Shekhar on the Convergence of Psychiatry, Neurology, and the Next Era of Brain Medicine

Power to the Patients

50:05

Ram Mukunda, CEO of IGC Pharma, on Innovation and Hope in Alzheimer’s Care

Power to the Patients

39:42